Universe Pharmaceuticals INC (UPC): Price and Financial Metrics
GET POWR RATINGS... FREE!
UPC Stock Summary
- UNIVERSE PHARMACEUTICALS INC's market capitalization of $12,615,000 is ahead of only 5.31% of US-listed equities.
- UNIVERSE PHARMACEUTICALS INC's stock had its IPO on March 23, 2021, making it an older stock than only 6.81% of US equities in our set.
- The volatility of UNIVERSE PHARMACEUTICALS INC's share price is greater than that of 92.72% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to UPC, based on their financial statements, market capitalization, and price volatility, are FALC, CLRO, CMCM, TACT, and GENC.
- UPC's SEC filings can be seen here. And to visit UNIVERSE PHARMACEUTICALS INC's official web site, go to www.dzrzy.com.
UPC Valuation Summary
- In comparison to the median Healthcare stock, UPC's price/sales ratio is 84.21% lower, now standing at 0.3.
- UPC's price/earnings ratio has moved down 14.6 over the prior 24 months.
Below are key valuation metrics over time for UPC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| UPC | 2023-03-24 | 0.3 | 0.3 | -1.4 | -1.4 |
| UPC | 2023-03-23 | 0.3 | 0.3 | -1.5 | -1.5 |
| UPC | 2023-03-22 | 0.3 | 0.3 | -1.5 | -1.5 |
| UPC | 2023-03-21 | 0.3 | 0.3 | -1.5 | -1.4 |
| UPC | 2023-03-20 | 0.3 | 0.3 | -1.5 | -1.4 |
| UPC | 2023-03-17 | 0.3 | 0.3 | -1.5 | -1.4 |
UPC Stock Price Chart Interactive Chart >
UPC Price/Volume Stats
| Current price | $0.59 | 52-week high | $2.08 |
| Prev. close | $0.59 | 52-week low | $0.50 |
| Day low | $0.59 | Volume | 4,386 |
| Day high | $0.62 | Avg. volume | 241,848 |
| 50-day MA | $0.69 | Dividend yield | N/A |
| 200-day MA | $0.89 | Market Cap | 12.83M |
Universe Pharmaceuticals INC (UPC) Company Bio
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Jiangxi, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.
Latest UPC News From Around the Web
Below are the latest news stories about UNIVERSE PHARMACEUTICALS INC that investors may wish to consider to help them evaluate UPC as an investment opportunity.
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the Company’s products were included in the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (the “Catalogue”), which was published by Beijing Health Commission on December 12, 2022. The included products are Banlangen Granules, Strong Loquat Extract, Pediatric Parac |
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementJi’an, Jiangxi, China, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on November 9, 2022, informing the Company that it has regained compliance with the Nasdaq’s minimum bid price requirement and the matter is closed. On J |
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022. |
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyJi’an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on July 15, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq List |
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce PlatformsJi’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd. (“Lian-Ou Health”), a high-tech company focusing on pharmaceuticals, technology, operation, sales, and services, to develop the Company’s digital marketing and expand its |
UPC Price Returns
| 1-mo | -1.68% |
| 3-mo | -59.31% |
| 6-mo | 4.42% |
| 1-year | -56.16% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -59.31% |
| 2022 | -11.31% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...